CAS: 940310-85-0; 4-Methyl-3-((1-Methyl-6-(Pyridin-3-yl)-1H-Pyrazolo[3,4-D]Pyrimidin-4-yl)Amino)-N-(3-(Trifluoromethyl)Phenyl)Benzamide

该化合物是一种合成有机化合物,其特征是其复杂的分子结构,包括多个芳香环和功能组.这种化合物的特点是苯丙胺核心,该核心由一个三氟甲基组和[3,4-d]细胞改变,有助于其潜在的生物活动.

结构式图片

欧盟法规

C&L通报

上下游产品

1-methyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidine-4-amine 3-bromo-4-methylbenzoic acid 3-bromo-4-methylbenzoyl chloride 3-trifluoromethylaniline

合成工艺路线路线简述

  • 123-06-8 + 7339-53-9 + 23410-19-7 + 59-67-6 = 940310-85-0
    反应条件:1.1 Reagents: Triethylamine Solvents: Ethanol; Rt1.2 Rt1.3 Reagents: Sulfuric Acid Solvents: Water; 10 - 15 °C; 1 H,10 - 15 °C1.4 Solvents: Water; Ph 8,Cooled1.5 2 H,Rt -> 180 °C1.6 Reagents: Water1.7 Reagents: Phosphorus Oxychloride; 3 H,Reflux1.8 Solvents: Tert-Butanol; 20 Min,Rt -> 150 °C
    标题:Preparation Of 3-(Substituted Amino)-Pyrazolo[3,4-D]Pyrimidines As Ephb4 Receptors And Vegfr2 Kinase Inhibitors
    参考文献:World Intellectual Property Organization]

    = 940310-85-0 [标题:Reaction Conditions
    标题:Preparation Of Heteroarylaminobenzamides As Receptor Tyrosine Kinase Inhibitors For Treatment Of Protein Kinase Modulation-Responsive Disease Or Disorder
    参考文献:United States]

    940516-19-8 + 91092-05-6 = 940310-85-0
    反应条件:1.1 Reagents: Cesium Carbonate Catalysts: Tris(Dibenzylideneacetone)Dipalladium,1,1′-(9,9-Dimethyl-9H-Xanthene-4,5-Diyl)Bis[1,1-Diphenylphosphine] Solvents: 1,4-Dioxane; 4 H,Rt -> 120 °C
    标题:Nvp-Bhg712: Effects Of Regioisomers On The Affinity And Selectivity Toward The Ephrin Family
    作者:Troester,Alix; Heinzlmeir,Stephanie; Berger,Benedict-Tilman; Gande,Santosh L.; Saxena,Krishna; Et Al
    参考文献:Chemmedchem 日期:2018 卷标:13(16) 页码:1629-1633]

    1692-25-7 + 2271317-00-9 = 940310-85-0
    反应条件:1.1 Reagents: Sodium Carbonate Catalysts: Dichloro[1,1′-Bis(Diphenylphosphino)Ferrocene]Palladium(Ii) Dichloromethane Addu... Solvents: 1,4-Dioxane,Water; 100 °C
    标题:Process For Preparation Of Substituted Penta- And Hexa-Heterocyclic Compounds,Drug Combination And Use Thereof
    参考文献:China
3-溴-4-甲基 苯甲酰氯置于tris-(Dibenzylideneacetone)Dipalladium(0),Caesium Carbonate,三乙胺,4,5-双二苯基膦-9,9-二甲基氧杂蒽体系中,用 1,4-二氧六环,二氯甲烷 作为反应溶剂,化学反应 25.0H,反应生成 Nvp-Bhg 712; 4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-D]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺
参考文献:Nvp-Bhg712:区域异构体对ephrin家族亲和力和选择性的影响
标题:Nvp-Bhg712:区域异构体对ephrin家族亲和力和选择性的影响
摘要:产生促红细胞反应生成素的肝细胞(eph)受体是跨膜受体酪氨酸激酶.它们的细胞外结构域特异性结合ephrin A / B配体,并且这种结合调节细胞内激酶的活性.eph是双向细胞间信号传导,控制细胞形态,粘附和迁移的关键参与者.它们越来越被认为是抗癌药物的靶标.我们分析了nvp-Bhg712(nvp)与epha2和ephb4的结合.出乎意料的是,所有测试的市售nvp样品竟然是抑制剂的区域异构体(nvpiso),最初在诺华专利申请中进行了描述.它们的区别仅在于单个甲基在两个相邻氮原子之一上的定位.相同质量的两种化合物显示出不同的结合模式.此外,
DOI:10.1002/cmdc.201800398

海关参考信息

专利信息


专利号:US-2025289827-A1
优先权日:2022-12-02
标 题:Morphic forms of a mutant braf degrader and methods of manufacture thereof
发明人:YU ROBERT T; HE MINSHENG; SCHNADERBECK MATTHEW J; KREGER BRIDGET; POLLOCK ROY MACFARLANE; JIANG SIYI; LI MEIQI; CHEN BOLU; LU JIANNAN
权利人:C4 THERAPEUTICS INC
摘要:Advantageous isolated morphic forms of (3R)-3-[6-[2-cyano-3-[[ethyl(methyl)sulfamoyl]amino]-6-fluorophenoxy]-4-oxoquinazolin-3-yl]-8-[2-[1-[3-(2,4-dioxo-1,3-diazinan-1-yl)-5-fluoro-1-methylindazol-6-yl]-4-hydroxypiperidin-4-yl]acetyl]-1-oxa-8-azaspiro[4.5]decane (Compound 1), which is a mutant BRAF degrader, and methods to prepare Compound 1 morphic forms for therapeutic applications are provided in the invention. The invention also provides improved methods for the synthesis of Compound 1, new pharmaceutical compositions comprising Compound 1, and new uses of Compound 1.
台州市科瑞生物技术有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.pharm-intermediates.com
企业联系电话:0576-88813233👤
📞台州市科瑞生物技术有限公司 ⚠️参考联系方式
联系人:金崇光
电话:0576-88813233
手机:13396860566
传真:0576-88813233
邮箱:sales@pharm-intermediates.com
通信地址: 台州市开发大道东段288号
邮编: 318000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:台州市开发大道东段288号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Li T, Wang H, Liu R, Wang X, Huang L, Wu Z, Yin X, Zou S, Duan P. The role of EphB4/ephrinB2 signaling in root repair after orthodontically-induced root resorption. Am J Orthod Dentofacial Orthop. 2021 Mar;159(3):e217-e232. doi: 10.1016/j.ajodo.2020.07.035. Epub 2021 Jan 22. 25(21):5115. doi: 10.3390/molecules25215115.
3: Broggini T, Piffko A, Hoffmann CJ, Ghori A, Harms C, Adams RH, Vajkoczy P, Czabanka M. Ephrin-B2-EphB4 communication mediates tumor-endothelial cell interactions during hematogenous spread to spinal bone in a melanoma metastasis model. Oncogene. 2020 Nov;39(47):7063-7075. doi: 10.1038/s41388-020-01473-y. Epub 2020 Sep 28.
10:1377. doi: 10.3389/fonc.2020.01377.

合成参考文献


参考文献:10.1124/mol.119.115964
摘要:Lee TD, Lee OW, Brimacombe KR, Chen L, Guha R, Lusvarghi S, Tebase BG, Klumpp-Thomas C, Robey RW, Ambudkar SV, Shen M, Gottesman MM, Hall MD. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular Pharmacology. 2019 Nov;96(5):629–40. doi: 10.1124/mol.119.115964.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知